2 unknown, 1 completed, 1 recruiting. 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Kiyuk Chang: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of 1 Month vs. 12 Months DAPT in Patients Undergoing PCI With Genoss® DES 1 Month vs. 12 Months DAPT - Coronary Artery Disease | Not applicable | Unknown | Kiyuk Chang | 2186 | 2022-04-01 | 2023-03-15 |
| SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study SGLT2 inhibitor - Myocardial Infarction, Diabetes Mellitus, Type 2 | Recruiting | Kiyuk Chang | 1000 | 2020-08-01 | 2025-01-03 | |
| Effect of Ticagrelor Versus Clopidogrel on Endothelial Dysfunction and Vascular Inflammation Ticagrelor, Clopidogrel - Endothelial Dysfunction, Vascular Inflammation | Phase 4 | Unknown | Kiyuk Chang | 38 | 2015-01-01 | 2016-07-06 |
| CardiOvascular Risk and idEntificAtion of Potential High-risk Population in Acute Myocardial Infarction Percutaneous coronary intervention - Long-term Major Cardiovascular Events, Myocardial Infarction | Completed | Kiyuk Chang | 4748 | 2004-01-01 | 2015-04-20 |
Myocardial Infarction (2) · Coronary Artery Disease (1) · Diabetes Mellitus, Type 2 (1)
2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine (1) · Clopidogrel (1) · Percutaneous Coronary Intervention (1) · Sodium-Glucose Transporter 2 Inhibitors (1) · Ticagrelor (1) · dapagliflozin (1) · empagliflozin (1) · ertugliflozin (1) · ipragliflozin (1)
South Korea (3)
Ki-Bae Seung, MD, PhD (1) · Myung Ho Jeong, MD, PhD (1)